Insider Transactions in Q1 2023 at Encompass Health Corp (EHC)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 27
2023
|
John Patrick Darby EVP, Gen Counsel & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
509
-0.67%
|
$30,540
$60.22 P/Share
|
|
Feb 27
2023
|
Andrew L Price Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
410
-0.56%
|
$24,600
$60.22 P/Share
|
|
Feb 27
2023
|
Mark J Tarr President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,895
-0.58%
|
$173,700
$60.22 P/Share
|
|
Feb 27
2023
|
Edmund Fay Sr. Vice Pres. and Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct |
383
-0.39%
|
$22,980
$60.22 P/Share
|
|
Feb 27
2023
|
Douglas E Coltharp EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,078
-0.96%
|
$64,680
$60.22 P/Share
|
|
Feb 27
2023
|
Elissa Joy Charbonneau Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
506
-1.59%
|
$30,360
$60.22 P/Share
|
|
Feb 24
2023
|
John Patrick Darby EVP, Gen Counsel & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
397
-0.52%
|
$23,820
$60.22 P/Share
|
|
Feb 24
2023
|
Andrew L Price Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
320
-0.44%
|
$19,200
$60.22 P/Share
|
|
Feb 24
2023
|
Mark J Tarr President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,256
-0.45%
|
$135,360
$60.22 P/Share
|
|
Feb 24
2023
|
Edmund Fay Sr. Vice Pres. and Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct |
299
-0.3%
|
$17,940
$60.22 P/Share
|
|
Feb 24
2023
|
Douglas E Coltharp EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
840
-0.74%
|
$50,400
$60.22 P/Share
|
|
Feb 24
2023
|
Elissa Joy Charbonneau Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
356
-1.1%
|
$21,360
$60.22 P/Share
|
|
Feb 23
2023
|
Douglas E Coltharp EVP & Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
60,488
+24.17%
|
-
|
|
Feb 23
2023
|
Mark J Tarr President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
78,327
+7.24%
|
-
|
|
Feb 23
2023
|
Elissa Joy Charbonneau Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,881
+11.4%
|
-
|
|
Feb 23
2023
|
John Patrick Darby EVP, Gen Counsel & Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
28,527
+17.27%
|
-
|
|
Feb 23
2023
|
Andrew L Price Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,114
+4.73%
|
-
|
|
Feb 23
2023
|
Edmund Fay Sr. Vice Pres. and Treasurer |
BUY
Grant, award, or other acquisition
|
Direct |
6,688
+3.32%
|
-
|
|
Feb 21
2023
|
Edmund Fay Sr. Vice Pres. and Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct |
278
-0.3%
|
$17,236
$62.86 P/Share
|
|
Feb 21
2023
|
Douglas E Coltharp EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
782
-1.47%
|
$48,484
$62.86 P/Share
|
|
Feb 21
2023
|
Mark J Tarr President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,100
-0.49%
|
$130,200
$62.86 P/Share
|
|
Feb 21
2023
|
Elissa Joy Charbonneau Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
332
-1.34%
|
$20,584
$62.86 P/Share
|
|
Feb 21
2023
|
John Patrick Darby EVP, Gen Counsel & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
369
-0.77%
|
$22,878
$62.86 P/Share
|
|
Feb 21
2023
|
Andrew L Price Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
298
-0.45%
|
$18,476
$62.86 P/Share
|
|
Feb 10
2023
|
Douglas E Coltharp EVP & Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
17,895
-25.21%
|
$1,073,700
$60.78 P/Share
|
|
Feb 10
2023
|
Douglas E Coltharp EVP & Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
17,895
+20.13%
|
$357,900
$20.07 P/Share
|
|
Jan 17
2023
|
Terrance Williams Director |
BUY
Grant, award, or other acquisition
|
Direct |
22
+0.24%
|
-
|
|
Jan 17
2023
|
Nancy M Schlichting Director |
BUY
Grant, award, or other acquisition
|
Direct |
37
+0.25%
|
-
|
|
Jan 17
2023
|
Greg D Carmichael Director |
BUY
Grant, award, or other acquisition
|
Direct |
22
+0.21%
|
-
|
|
Jan 17
2023
|
Donald L Correll Director |
BUY
Grant, award, or other acquisition
|
Direct |
233
+0.24%
|
-
|
|
Jan 17
2023
|
Christopher R Reidy Director |
BUY
Grant, award, or other acquisition
|
Direct |
16
+0.13%
|
$480
$30.75 P/Share
|
|
Jan 17
2023
|
Patricia Anne Maryland Director |
BUY
Grant, award, or other acquisition
|
Direct |
22
+0.25%
|
-
|
|
Jan 17
2023
|
Kevin J. O'Connor Director |
BUY
Grant, award, or other acquisition
|
Direct |
8
+0.2%
|
-
|
|
Jan 17
2023
|
Leslye G Katz Director |
BUY
Grant, award, or other acquisition
|
Direct |
99
+0.24%
|
-
|
|
Jan 17
2023
|
John Chidsey Director |
BUY
Grant, award, or other acquisition
|
Direct |
906
+0.29%
|
$27,180
$30.83 P/Share
|
|
Jan 17
2023
|
Joan E Herman Director |
BUY
Grant, award, or other acquisition
|
Direct |
99
+0.24%
|
-
|
|
Jan 03
2023
|
Douglas E Coltharp EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,449
-10.83%
|
$380,491
$59.81 P/Share
|
|
Jan 03
2023
|
Mark J Tarr President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
14,576
-3.31%
|
$859,984
$59.81 P/Share
|
|
Jan 03
2023
|
Elissa Joy Charbonneau Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,477
-5.64%
|
$87,143
$59.81 P/Share
|
|
Jan 03
2023
|
Edmund Fay Sr. Vice Pres. and Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,259
-1.34%
|
$74,281
$59.81 P/Share
|
|
Jan 03
2023
|
John Patrick Darby EVP, Gen Counsel & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
3,113
-6.11%
|
$183,667
$59.81 P/Share
|
|
Jan 03
2023
|
Andrew L Price Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,344
-1.99%
|
$79,296
$59.81 P/Share
|